ID
18454
Beskrivning
Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2; ODM derived from: https://clinicaltrials.gov/show/NCT00085839
Länk
https://clinicaltrials.gov/show/NCT00085839
Nyckelord
Versioner (1)
- 2016-11-06 2016-11-06 -
Uppladdad den
6 november 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Non-Small Cell Lung Cancer NCT00085839
Eligibility Non-Small Cell Lung Cancer NCT00085839
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beskrivning
Abnormality of the gastrointestinal tract
Datatyp
boolean
Alias
- UMLS CUI [1]
- C4023588
Beskrivning
cancer treatment
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0920425
Beskrivning
Epidermal growth factor receptor inhibitor
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1443775
Beskrivning
Malignant Neoplasms
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0006826
Beskrivning
Metastatic malignant neoplasm to brain Uncontrolled
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0220650
- UMLS CUI [1,2]
- C0205318
Beskrivning
Abnormality of the cornea Severe
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C1855670
- UMLS CUI [1,2]
- C0205082
Beskrivning
Heart Disease Significant
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0018799
- UMLS CUI [1,2]
- C0750502
Similar models
Eligibility Non-Small Cell Lung Cancer NCT00085839
- StudyEvent: Eligibility
C3258246 (UMLS CUI [2])
C0205210 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C0205483 (UMLS CUI [2,2])
C0205318 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,2])